那么，如果不通过对手们所热衷的合并，他计划如何拯救阿斯特捷利康呢？
So how does he plan to save AstraZeneca, if not through the merger mania now intoxicating his rivals?
在去年英国基准指标富时100指数股票中，阿斯特捷利康是表现最好的股票之一。
Its shares were among the best-performing in Britain's benchmark FTSE 100 index last year.
投行公司荷兰国际集团（ING）在一项新报告中警告，由于阿斯特捷利康公司畅销药物的专利权将在未来几年中过期，公司将冒险进入“知识产权崩溃期”。
A new report from ING, an investment bank, warns that as the patents on AstraZeneca’s blockbusters expire in the coming years the firm risks going into “intellectual property meltdown”.
摩根·斯坦利的BalajiJayaraman补充说，购买捷豹和陆虎明显是：“破坏品牌价值，缺乏整合效应并且会带来高额运营成本。”
Balaji Jayaraman of Morgan Stanley added that buying JLR was clearly "value-destructive given the lack of synergies and the high-cost operations involved."
摩根·斯坦利的BalajiJayaraman补充说，购买捷豹和陆虎明显是：“破坏品牌价值，缺乏整合效应并且会带来高额运营成本。”
Balaji Jayaraman of Morgan Stanley added that buying JLR was clearly "value-destructive given the lack of synergies and the high-cost operations involved."
应用推荐